Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

China

Henan Cancer Hospital, Zhengzhou, Henan

Zhongnan Hospital of Wuhan University, Wuhan, Hubei

The First People's Hospital of Changzhou, Changzhou, Jiangsu

Huai 'an First People's Hospital, Huaian, Jiangsu

Zhongda Hospital, Nanjing, Jiangsu

Jiangsu Province Hospital, Nanjing, Jiangsu

ShengJing Hospital, Shenyang, Liaoning

Qilu Hospital of Shandong University, Jinan, Shangdong

Tongren Hospital Shanghai Jiao Tong University School Of Medicine, Shanghai, Shanghai Municipality

Ruijin hospitol, Shanghai, Shanghai Municipality